Project Pheonix: THE ADRENALINE ® SURGE - 3:

In a groundbreaking comparative study, the performance of ADRENALINE ® N4960 was evaluated against its predecessor, ADRENALINE ® N4950, within EW (Emulsifiable Concentrate) formulations and Suspo Emulsion (SE) formulations. Both surfactants, renowned for their polymeric nature, were scrutinized to determine the advancements brought by the newer molecule. The results were compelling: ADRENALINE ® N4960 emerged as a superior innovation, showcasing significantly lower viscosity, which translates to enhanced handling and a better pour point. This improvement not only facilitates easier application but also ensures more efficient processing. Additionally, the slightly higher molecular weight of ADRENALINE ® N4960 contributes to its exceptional stability and anchoring capabilities, making it a robust choice for various formulations. Beyond its technical merits, ADRENALINE ® N4960 also proves to be more cost-efficient, offering economic advantages without compromising on performance. This study underscores the innovative leap represented by ADRENALINE ® N4960, setting a new benchmark in the realm of polymeric surfactants and paving the way for more efficient and stable EW formulations.